157 related articles for article (PubMed ID: 2971358)
1. Antagonism of 5-hydroxytryptamine1A (5-HT1A) receptor-mediated modulation of adenylate cyclase activity by pindolol and propranolol isomers.
Oksenberg D; Peroutka SJ
Biochem Pharmacol; 1988 Sep; 37(18):3429-33. PubMed ID: 2971358
[TBL] [Abstract][Full Text] [Related]
2. 5-Hydroxytryptamine1A receptors are linked to a Gi-adenylate cyclase complex in rat hippocampus.
Harrington MA; Oksenberg D; Peroutka SJ
Eur J Pharmacol; 1988 Sep; 154(1):95-8. PubMed ID: 2972552
[TBL] [Abstract][Full Text] [Related]
3. NAN-190: agonist and antagonist interactions with brain 5-HT1A receptors.
Rydelek-Fitzgerald L; Teitler M; Fletcher PW; Ismaiel AM; Glennon RA
Brain Res; 1990 Nov; 532(1-2):191-6. PubMed ID: 2282513
[TBL] [Abstract][Full Text] [Related]
4. Activity of serotonin (5-HT) receptor agonists, partial agonists and antagonists at cloned human 5-HT1A receptors that are negatively coupled to adenylate cyclase in permanently transfected HeLa cells.
Pauwels PJ; Van Gompel P; Leysen JE
Biochem Pharmacol; 1993 Jan; 45(2):375-83. PubMed ID: 8382063
[TBL] [Abstract][Full Text] [Related]
5. Centrally acting hypotensive agents with affinity for 5-HT1A binding sites inhibit forskolin-stimulated adenylate cyclase activity in calf hippocampus.
Schoeffter P; Hoyer D
Br J Pharmacol; 1988 Nov; 95(3):975-85. PubMed ID: 3207999
[TBL] [Abstract][Full Text] [Related]
6. Studies of the biochemical basis for the discriminative properties of 8-hydroxy-2-(di-n-propylamino)tetralin.
Rabin RA; Winter JC
Eur J Pharmacol; 1993 Apr; 235(2-3):237-43. PubMed ID: 8508905
[TBL] [Abstract][Full Text] [Related]
7. Differential interactions of dimethyltryptamine (DMT) with 5-HT1A and 5-HT2 receptors.
Deliganis AV; Pierce PA; Peroutka SJ
Biochem Pharmacol; 1991 Jun; 41(11):1739-44. PubMed ID: 1828347
[TBL] [Abstract][Full Text] [Related]
8. Nucleotide interactions with 5-HT1A binding sites directly labeled by [3H]-8-hydroxy-2-(DI-n-propylamino)tetralin ([3H]-8-OH-DPAT).
Schlegel JR; Peroutka SJ
Biochem Pharmacol; 1986 Jun; 35(12):1943-9. PubMed ID: 3013203
[TBL] [Abstract][Full Text] [Related]
9. 5-HT1B receptors are negatively coupled with adenylate cyclase in rat substantia nigra.
Bouhelal R; Smounya L; Bockaert J
Eur J Pharmacol; 1988 Jul; 151(2):189-96. PubMed ID: 2971554
[TBL] [Abstract][Full Text] [Related]
10. Pertussis toxin attenuates 5-hydroxytryptamine1A receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in rat hippocampal membranes.
Okada F; Tokumitsu Y; Nomura Y
J Neurochem; 1989 May; 52(5):1566-9. PubMed ID: 2523468
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the 5-hydroxytryptamine1a receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in guinea pig and rat hippocampal membranes.
De Vivo M; Maayani S
J Pharmacol Exp Ther; 1986 Jul; 238(1):248-53. PubMed ID: 2941565
[TBL] [Abstract][Full Text] [Related]
12. Lack of apparent receptor reserve at postsynaptic 5-hydroxytryptamine1A receptors negatively coupled to adenylyl cyclase activity in rat hippocampal membranes.
Yocca FD; Iben L; Meller E
Mol Pharmacol; 1992 Jun; 41(6):1066-72. PubMed ID: 1352034
[TBL] [Abstract][Full Text] [Related]
13. 6-substituted tricyclic partial ergoline compounds are selective and potent 5-hydroxytryptamine1A receptor agents.
Slaughter JL; Harrington MA; Peroutka SJ
Life Sci; 1990; 47(15):1331-7. PubMed ID: 2172684
[TBL] [Abstract][Full Text] [Related]
14. The GTP-insensitive component of high-affinity [3H]8-hydroxy-2-(di-n-propylamino)tetralin binding in the rat hippocampus corresponds to an oxidized state of the 5-hydroxytryptamine1A receptor.
Emerit MB; Miquel MC; Gozlan H; Hamon M
J Neurochem; 1991 May; 56(5):1705-16. PubMed ID: 1826520
[TBL] [Abstract][Full Text] [Related]
15. Intrinsic activity of enantiomers of 8-hydroxy-2-(di-n-propylamino)tetralin and its analogs at 5-hydroxytryptamine1A receptors that are negatively coupled to adenylate cyclase.
Cornfield LJ; Lambert G; Arvidsson LE; Mellin C; VallgÄrda J; Hacksell U; Nelson DL
Mol Pharmacol; 1991 Jun; 39(6):780-7. PubMed ID: 1828859
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of forskolin-stimulated adenylate cyclase activity by 5-HT receptor agonists.
Devivo M; Maayani S
Eur J Pharmacol; 1985 Dec; 119(3):231-4. PubMed ID: 2936612
[TBL] [Abstract][Full Text] [Related]
17. Effects of postmortem delay on serotonin and (+)8-OH-DPAT-mediated inhibition of adenylyl cyclase activity in rat and human brain tissues.
Palego L; Giromella A; Marazziti D; Borsini F; Naccarato AG; Giannaccini G; Lucacchini A; Cassano GB; Mazzoni MR
Brain Res; 1999 Jan; 816(1):165-74. PubMed ID: 9878719
[TBL] [Abstract][Full Text] [Related]
18. Interactions of (+)- and (-)-8- and 7-hydroxy-2-(di-n-propylamino)tetralin at human (h)D3, hD2 and h serotonin1A receptors and their modulation of the activity of serotoninergic and dopaminergic neurones in rats.
Lejeune F; Newman-Tancredi A; Audinot V; Millan MJ
J Pharmacol Exp Ther; 1997 Mar; 280(3):1241-9. PubMed ID: 9067310
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a novel and potent 5-hydroxytryptamine1A receptor antagonist.
Liau LM; Sleight AJ; Pitha J; Peroutka SJ
Pharmacol Biochem Behav; 1991 Mar; 38(3):555-9. PubMed ID: 1648748
[TBL] [Abstract][Full Text] [Related]
20. 5-HT1A-receptors mediate stimulation of adenylate cyclase in rat hippocampus.
Markstein R; Hoyer D; Engel G
Naunyn Schmiedebergs Arch Pharmacol; 1986 Aug; 333(4):335-41. PubMed ID: 2945992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]